Phenotypic screening reveals topoisomerase I as a breast cancer stem cell therapeutic target
about
Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.Modification of topoisomerases in mammospheres derived from breast cancer cell line: clinical implications for combined treatments with tyrosine kinase inhibitors.Topoisomerase I inhibitors, shikonin and topotecan, inhibit growth and induce apoptosis of glioma cells and glioma stem cells.Getting to the source: selective drug targeting of cancer stem cells.
P2860
Phenotypic screening reveals topoisomerase I as a breast cancer stem cell therapeutic target
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Phenotypic screening reveals t ...... r stem cell therapeutic target
@ast
Phenotypic screening reveals t ...... r stem cell therapeutic target
@en
type
label
Phenotypic screening reveals t ...... r stem cell therapeutic target
@ast
Phenotypic screening reveals t ...... r stem cell therapeutic target
@en
prefLabel
Phenotypic screening reveals t ...... r stem cell therapeutic target
@ast
Phenotypic screening reveals t ...... r stem cell therapeutic target
@en
P2093
P2860
P356
P1433
P1476
Phenotypic screening reveals t ...... r stem cell therapeutic target
@en
P2093
Edward V Prochownik
Fang Zhang
Kristi Rothermund
Sajithlal B Gangadharan
P2860
P304
P356
10.18632/ONCOTARGET.632
P407
P577
2012-09-01T00:00:00Z